Skip to content

Protein-energy Enriched Milk for Infants With Bronchiolitis

Protein-energy Enriched Milk for Infants With Bronchiolitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02316015
Acronym
PEMIB
Enrollment
44
Registered
2014-12-12
Start date
2014-12-31
Completion date
2016-04-30
Last updated
2015-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis

Keywords

Child, Hospitalized, Nutritional status

Brief summary

The aim of this study is to investigate if a standardized nutritional intervention with a protein and energy enriched milk could help overcome the catabolic state in children hospitalized with a bronchiolitis and thus creating a better nutritional state during hospitalization and at outpatient follow-up. The investigators also want to assess the clinical repercussion on the number of hospitalization days, the duration of oxygen support and the quality of life at ouptatient follow-up.

Detailed description

In this study, the investigators aim to assess the effect protein-energy enriched milk to reverse the catabolic state (weight loss, change in mid-upper arm circumference and tricpes skin fold) on the short term and failure to thrive (degree of weight recovery, change in arm circumference) one week after discharge in infants with moderate to severe bronchiolitis. The secondary short term aims are to investigate the effect on the length of hospital stay, days of oxygen support and the rate of antibiotic use. Secondary long term outcomes are the re-admission rate, the persistence of wheezing and the number of work days missed by the parents. The investigators hypothesize that in those children who received a protein-energy enriched milk during hospitalization the catabolic state will be reversed more quickly by the intervention and will need less hospitalisation days, less oxygen support, less antibiotic use, less re-admission rate, less persistent wheezing and less work days missed by the parents. The investigators also hypothesize that the effects of the nutritional intervention on the proposed outcome parameters will be greater in children screened at high nutritional risk.

Interventions

DIETARY_SUPPLEMENTInfatrini® or Infatrini Peptisorb®

Sponsors

Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 2 Years
Healthy volunteers
No

Inclusion criteria

* All children hospitalized at the paediatric wards of UZ Brussel with the diagnosis of moderate to severe bronchiolitis * Not meeting their normal oral intake are eligible for inclusion between the beginning of December and the end of February 2014 * Bronchiolitis will be defined as a constellation of clinical symptoms and signs that typically begin with rhinitis and cough, and may progress to tachypnea, wheezing, rales, use of accessory muscles and/or nasal flaring

Exclusion criteria

* Children admitted to the paediatric intensive care unit * Children in whom it is unsafe to place a nasogastric tube (e.g. severe mucositis, platelet count \<50.000/µl) * Children unwilling or unable to participate * Children that are breast fed * Children over the age of 12 months * Children with an underlying malabsorption disease

Design outcomes

Primary

MeasureTime frameDescription
Evolution of nutritional status during hospitalizationHospital stay (mean 5 days)The change in followong parameters will be assessed: * Change in weight for age z-score * Change in mid upper arm circumference z-score * Change in triceps skin fold (mm)

Secondary

MeasureTime frameDescription
Evolution of nutritional status at outpatient follow-up1 week after discharge\- Change in WFA z-score, weight for height z-score, MUAC z-score and TSF (mm)

Other

MeasureTime frameDescription
Time of oxygen supportHospital stay (mean 5 days)Number of hours of oxygen support during hospital stay
Rate of antibiotic useHospital stay (mean 5 days)Number of children in which antibiotics is commenced during their hospitalization
The Quality of life at outpatient follow-up1 week after dischargeThe ITQOL-SF47 questionnaire will be used to assess quality of life
Persistence of wheezing1 week after dischargeThis will be assessed using the respiratory distress assessment instrument (Langley et al., 2005)
Re-admission rate1 week after dischargeNumber of children that are re-admitted to the hospital in the first two months after discharge
Duration of hospital stayHospital stay (mean 5 days)Number of days of hospitalization

Countries

Belgium

Contacts

Primary ContactKoen Huysentruyt, MD
koen.huysentruyt@uzbrussel.be+3224763717
Backup ContactKlaar Vergaelen, MD
Klaar.vergaelen@uzbrussel.be+3224774389

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026